Neuronetics (NASDAQ:STIM) Given Market Perform Rating at William Blair

William Blair reissued their market perform rating on shares of Neuronetics (NASDAQ:STIM – Free Report) in a research note published on Tuesday morning, RTT News reports. Separately, Piper Sandler reaffirmed an overweight rating and issued a $8.00 target price (up from $7.00) on shares of Neuronetics in a research note on Wednesday, March 6th. Read […]

Related Keywords

United States ,William Blair ,Piper Sandler ,Keithj Sullivan ,Kent Lake Capital ,Neuronetics Inc ,Neuronetics Company Profile ,Nantahala Capital Management ,Millrace Asset Group Inc ,Securities Exchange Commission ,Free Report ,Get Free Report ,Exchange Commission ,Lake Capital ,Capital Management ,Asset Group ,Divisadero Street Capital Management ,Street Capital Management ,Neurostar Advanced Therapy System ,Neuronetics Daily ,